XERIS BIOPHARMA HOLDINGS, INC. (XERS)

Import this data to Google Sheets with:

=jivedata("XERS","financials")

Full statements spill as a table. For one cell: =jivedata("XERS","Revenue") or =jivedata("XERS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

XERIS BIOPHARMA HOLDINGS, INC.

XERS • CIK 0001867096

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$163,914	$203,070	$291,845	$335,414
Income (Loss) Attributable to Parent, before Tax	$-63,504	$-57,104	$554	$-17,165
Income Tax Expense (Benefit)	$-1,249	$-2,268	$0	$0
Net Income (Loss) Attributable to Parent	$-62,255	$-54,836	$554	$-17,165
Weighted Average Number of Shares Outstanding, Basic	137,674,857	146,772,758	160,425,198	176,132,836
Weighted Average Number of Shares Outstanding, Diluted	137,674,857	146,772,758	172,742,720	188,450,358
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization	$28,645	$36,832	$42,569	$45,029
Research and Development Expense	$22,341	$25,560	$31,165	$34,809
Selling, General and Administrative Expense	$146,095	$163,481	$182,372	$208,140
Amortization of Intangible Assets	$10,843	$10,843	$10,843	$10,843
Operating Costs and Expenses	$207,924	$236,716	$266,949	$298,821
Operating Income (Loss)	$-44,010	$-33,646	$24,896	$36,593
Interest Income, Other	$4,751	$5,321	$4,742	$5,276
Gain (Loss) on Extinguishment of Debt	$-2,837	$0	$0	$-30,782
InterestExpenseNonoperating	—	$30,485	$29,084	$28,252
Fair Value Adjustment of Warrants	$-1	$-8	$0	$0
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$-5,200	$-4,388	$0	$0
Other Nonoperating Income (Expense)	$-19,494	$-23,458	$-24,342	$-53,758
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax	$-2	$0	$0	$0
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-62,257	$-54,836	$554	$-17,151
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	45,080,778	49,245,174	12,441,368	1,735,377

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Accounts Receivable, after Allowance for Credit Loss, Current	$39,197	$40,415	$51,050	$58,105
Inventory, Net	$38,838	$48,175	$68,673	$80,930
Property, Plant and Equipment, Net	$5,971	$5,562	$4,945	$4,834
Prepaid Expense, Current	$5,778	$7,451	$9,548	$13,975
Operating Lease, Right-of-Use Asset	$23,204	$22,649	$22,112	$21,773
Long-term Debt, Excluding Current Maturities	—	$217,006	$220,335	$188,807
Assets, Current	$156,264	$167,662	$240,313	$274,757
Goodwill	$22,859	$22,859	$22,859	$22,859
Operating Lease, Liability, Noncurrent	$34,764	$33,259	$31,531	$30,542
Intangible Assets, Net (Excluding Goodwill)	$109,764	$98,921	$88,078	$82,657
Other Liabilities, Noncurrent	$4,848	$1,967	$8,398	$12,722
Other Assets, Noncurrent	$4,540	$5,407	$5,220	$5,025
Liabilities	$329,384	$352,675	$369,838	$421,639
Assets	$322,602	$323,060	$383,527	$411,905
Cash and Cash Equivalents, at Carrying Value	$67,449	$71,621	$111,042	$121,747
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$14	$15	$17	$18
Additional Paid in Capital	$610,254	$642,256	$685,004	$690,432
Retained Earnings (Accumulated Deficit)	$-617,025	$-671,861	$-671,307	$-700,174
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-25	$-25	$-25	$-10
Stockholders' Equity Attributable to Parent	$-6,782	$-29,615	$13,689	$-9,734
Accounts Payable, Current	$11,565	$2,290	$3,076	$9,337
Long-term Debt, Current Maturities	—	$15,102	$0	$63,783
Operating Lease, Liability, Current	$3,495	$6,080	$6,232	$6,310
Accrued Liabilities, Current	$23,510	$27,716	$33,155	$39,706
Other Liabilities, Current	$1,167	$1,089	$4,889	$4,976
Liabilities, Current	$95,193	$100,443	$109,574	$189,568
Preferred Stock, Shares Authorized	25,000,000	25,000,000	25,000,000	25,000,000
Preferred Stock, Shares Outstanding	0	0	0	0
Common Stock, Shares Authorized	350,000,000	350,000,000	350,000,000	350,000,000
Common Stock, Shares, Issued	138,130,715	149,429,410	166,215,410	173,591,637

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-62,255	$-54,836	$554	$-17,165
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-54,640	$4,070	$39,319	$62,360
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$71,674	$75,744	$115,063	$168,271
Depreciation, Depletion and Amortization	$1,487	$1,227	$1,313	$1,333
Amortization of Intangible Assets	$10,843	$10,843	$10,843	$10,843
Accretion (Amortization) of Discounts and Premiums, Investments	$1,263	$747	$0	$0
Amortization of Debt Issuance Costs	$2,205	$3,007	$3,373	$3,505
Operating Lease, Right-of-Use Asset, Amortization Expense	$830	$555	$537	$630
Deferred Income Tax Expense (Benefit)	$-1,249	$-2,268	$0	$0
Share-based Payment Arrangement, Noncash Expense	$10,716	$18,363	$22,366	$28,121
Gain (Loss) on Extinguishment of Debt	$-2,837	$0	$0	$-30,782
Other Operating Activities, Cash Flow Statement	—	—	$0	$0
Payments to Acquire Investments	$43,741	$34,485	$0	$0
Proceeds from Sale, Maturity and Collection of Investments	$40,000	$40,236	$0	$0
Net Cash Provided by (Used in) Investing Activities	$-6,004	$4,883	$-696	$-938
Payments of Debt Issuance Costs	$1,185	$0	$0	$0
Proceeds from Stock Plans	$549	$1,244	$1,520	$1,675
Proceeds from Stock Options Exercised	$32	$489	$11,578	$7,141
Proceeds from Issuance of Warrants	—	—	$9,167	$17,100
Payment, Tax Withholding, Share-based Payment Arrangement	$1,009	$3,734	$10,876	$19,226
Net Cash Provided by (Used in) Financing Activities	$-1,613	$36,168	$11,389	$6,690
Interest Paid, Excluding Capitalized Interest, Operating Activities	$27,686	$26,948	$27,120	$24,755
Stock Issued During Period, Value, Conversion of Convertible Securities	—	—	$15,146	$0
Cash and Cash Equivalents, at Carrying Value	$67,449	$71,621	$111,042	$164,352
Restricted Cash, Noncurrent	$4,225	$4,123	$4,021	$3,919
Increase (Decrease) in Accounts Receivable	$8,367	$1,218	$10,635	$5,057
Increase (Decrease) in Prepaid Expense	$-3,206	$1,673	$2,097	$8,244
Increase (Decrease) in Inventories	$14,804	$8,782	$19,286	$16,747
Increase (Decrease) in Accounts Payable	$6,959	$-9,613	$-69	$4,834
Increase (Decrease) in Accrued Liabilities	$-5,855	$3,650	$3,306	$3,527
IncreaseDecreaseInOperatingLeaseLiability	$7,538	$1,080	$-1,576	$-1,745
Increase (Decrease) in Other Operating Liabilities	$3,393	$-1,072	$3,723	$2,928
Net Cash Provided by (Used in) Operating Activities	$-47,023	$-36,981	$28,626	$56,608

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("XERS","financials")

Full statements spill as a table. For one cell: =jivedata("XERS","Revenue") or =jivedata("XERS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.